Gilles Rubinstenn – Biography
Last update: March 18, 2026Executive profile
Gilles Rubinstenn is currently
Chairman of the Board and Chief Innovation Officer at ReST Therapeutics - View - ReST Therapeutics org chart
Create your alert
to follow the career of Gilles Rubinstenn.
More about Gilles Rubinstenn
Do you need to know more about Gilles Rubinstenn? More results.
Participate
Social media
- Gilles Rubinstenn on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Gilles Rubinstenn
The colleagues of Gilles Rubinstenn
Company Colleagues
- At ReST Therapeutics, Gilles Rubinstenn has 4 colleagues including Anthony Franco (CEO), Philippe Guerret (Director)…
Industry Colleagues
- In the Biotechnology industry, Gilles Rubinstenn has 35,756 colleagues in 2,406 companies located in 42 countries. 16,877 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Gilles Rubinstenn.
Get in Touch
Here are a few tips for establishing great contacts.
Through the switchboard, call ReST Therapeutics at +33 46... and ask for Gilles Rubinstenn.
